Trial Profile
A Clinical Trial to Evaluate the Pharmacokinetics of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin Ca Under Fed Condition in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fenofibrate/pitavastatin (Primary) ; Fenofibrate; Pitavastatin
- Indications Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Hanlim Pharmaceutical
- 01 Aug 2018 Status changed from active, no longer recruiting to completed.
- 06 Oct 2014 New trial record